Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

FDA changes Plan B label, clarifies it won't cause abortion

Por: Associated Press Politics December 24, 2022

WASHINGTON (AP) — The Food and Drug Administration announced Friday that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy. The federal agency said it will remove references on the contraception’s packaging that claim, without scientific evidence, that the pill prevents a fertilized egg from implanting in the womb. The new labels are intended to further... + full article



Similar News

FDA will greenlight pharmacies to fill prescriptions for abortion pill, agency says

ABC7 USA Health January 04, 2023

thumbnailThe abortion drug mifepristone is safe enough that local pharmacies can provide the drug so long as it's prescribed by a certified healthcare provider and if that pharmacy meets certain requirements, according to new rules published Tuesday by the US Food and Drug... + más

FDA says it will greenlight pharmacies to fill prescriptions for abortion pill | ABC7

Will Pharmacies Really Make Abortion Pills More Accessible? | Time


FDA says it will greenlight pharmacies to fill prescriptions for abortion pill

ABC7 USA World January 04, 2023

thumbnailby the U.S. Food and Drug Administration.If pharmacies jump on board, the FDA action could dramatically expand access to the drug in states where it's already legal. Doctors, for example, might be more willing to get certified to prescribe the drug because they would no... + más

FDA will greenlight pharmacies to fill prescriptions for abortion pill, agency says | ABC7

Will Pharmacies Really Make Abortion Pills More Accessible? | Time


House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug

Politico USA Health December 30, 2022

thumbnailThe FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más

Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times

Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News


Panel warns FDA’s beleaguered tobacco unit lacks direction

ABC News USA Health December 20, 2022

thumbnailWASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


Panel warns FDA’s beleaguered tobacco unit lacks direction

WPLG Local 10 USA Politics December 20, 2022

thumbnailWASHINGTON – The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press


Panel warns FDA’s beleaguered tobacco unit lacks direction

Associated Press USA Politics December 19, 2022

thumbnailWASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más

Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News

Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10



About iurex | Privacy Policy | Disclaimer |